Lenalidomide in 5q minus myelodysplastic syndrome: how long is enough?

被引：4

作者：

Duerr, Donat ^{[1
]}

Siciliano, Raffaele Daniele ^{[1
]}

Hummel, Yvonne ^{[1
]}

O'Meara, Alix ^{[1
]}

Hirschi, Anita ^{[1
]}

Burkhard, Roger ^{[1
]}

Honegger, Hanspeter ^{[1
]}

机构：

[1] Stadtspital Triemli, CH-8063 Zurich, Switzerland

来源：

ANNALS OF HEMATOLOGY | 2010年 / 89卷 / 01期

关键词：

DELETION; MANAGEMENT; DEL(5Q);

D O I：

10.1007/s00277-009-0775-x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：105 / 106

页数：2

共 42 条

[1] Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion [J].

Duong, Vu H. ;

Komrokji, Rami S. ;

List, Alan F. .

THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (02) :105-116

[2] Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations [J].

Mallo, Mar ;

del Rey, Monica ;

Ibanez, Mariam ;

Jose Calasanz, Ma ;

Arenillas, Leonor ;

Jose Larrayoz, Ma ;

Pedro, Carmen ;

Jerez, Andres ;

Maciejewski, Jaroslaw ;

Costa, Dolors ;

Nomdedeu, Meritxell ;

Diez-Campelo, Maria ;

Lumbreras, Eva ;

Gonzalez-Martinez, Teresa ;

Marugan, Isabel ;

Such, Esperanza ;

Cervera, Jose ;

Cigudosa, Juan C. ;

Alvarez, Sara ;

Florensa, Lourdes ;

Hernandez, Jesus Ma ;

Sole, Francesc .

BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (01) :74-86

[3] Efficacy to lenalidomide treatment and complete cytogenetic remission in a case of myelodysplastic syndrome with del(5q) and del(9q) [J].

Xiong, Bei ;

Liu, XinYue ;

Zou, Ping ;

Fan, LiHua ;

Chen, WanXin ;

Li, WeiMing ;

Liu, Lin .

LEUKEMIA RESEARCH, 2010, 34 (07) :E169-E172

[4] The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes [J].

Melchert, Magda ;

Kale, Vishakha ;

List, Alan .

CURRENT OPINION IN HEMATOLOGY, 2007, 14 (02) :123-129

[5] SURVIVAL OF PATIENTS WITH DE NOVO MYELODYSPLASTIC SYNDROME AND del(5q) [J].

Gritsaev, S. V. ;

Martynkevich, I. S. ;

Petrova, E. V. ;

Martynenko, L. S. ;

Kostroma, I. I. ;

Ivanova, M. P. ;

Tsybakova, N. Yu. ;

Kozlovskaya, M. A. ;

Sergeyev, A. N. ;

Tiranova, S. A. ;

Potikhonova, N. A. ;

Abdulkadyrov, K. M. .

GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2013, 58 (01) :3-9

[6] Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutation [J].

Nomdedeu, Meritxell ;

Maffioli, Margherita ;

Calvo, Xavier ;

Martinez-Trillos, Alejandra ;

Baumann, Tycho ;

Diaz-Beya, Marina ;

Aguilar, Josep-Lluis ;

Rozman, Maria ;

Costa, Dolors ;

Esteve, Jordi ;

Cervantes, Francisco ;

Colomer, Dolors ;

Nomdedeu, Benet .

LEUKEMIA RESEARCH, 2011, 35 (09) :1276-1278

[7] Two different del(5q) clones in a patient with myelodysplastic syndrome [J].

Braulke, Friederike ;

Schanz, Julie ;

Steffens, Rainer ;

Liehr, Thomas ;

Manvelyan, Marina ;

Chudoba, Ilse ;

Haase, Detlef .

LEUKEMIA & LYMPHOMA, 2011, 52 (09) :1811-1814

[8] Short- and long-term benefits of lenalidomide treatment in patients with lower-risk del(5q) myelodysplastic syndromes [J].

Komrokji, R. S. ;

List, A. F. .

ANNALS OF ONCOLOGY, 2016, 27 (01) :62-68

[9] Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q-deletion [J].

Defina, Marzia ;

Rondoni, Michela ;

Gozzetti, Alessandro ;

Aprile, Lara ;

Chitarrelli, Ida ;

Fabbri, Alberto ;

Lauria, Francesco ;

Bocchia, Monica .

BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (03) :483-484

[10] Age, Blasts, Performance Status and Lenalidomide Therapy Influence the Outcome of Myelodysplastic Syndrome With Isolated Del(5q): A Study of 58 South American Patients [J].

Azevedo, R. S. ;

Belli, C. ;

Bassolli, L. ;

Ferri, L. ;

Perusini, M. A. ;

Enrico, A. ;

Pereira, T. D. M. ;

Junior, W. F. S. ;

Buccheri, V ;

Pinheiro, R. F. ;

Magalhaes, S. M. ;

Schuster, S. ;

Castelli, J. B. ;

Traina, F. ;

Rocha, V ;

Velloso, E. D. R. P. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (01) :E1-E6

← 1 2 3 4 5 →